hydrazine has been researched along with Dyskeratosis Congenita, X-Linked in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brümmendorf, TH; Ehninger, G; Jakob, C; Platzbecker, U; Schleyer, E; Siegert, G; Trautmann, K; von Grünhagen, U | 1 |
1 other study(ies) available for hydrazine and Dyskeratosis Congenita, X-Linked
Article | Year |
---|---|
Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and diamond-blackfan-anaemia.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Diamond-Blackfan; Benzoates; Cardiology; Dyskeratosis Congenita; Female; Humans; Hydrazines; Male; Megakaryocytes; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia; Treatment Outcome | 2012 |